The reduced sensitivity of the OSU‐CLLTP53ko cells, but not primary CLL cells with TP53 lesions, to ONC‐212 may be due to differences in the clonal frequency of the TP53 lesions between the cells. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.